Defence technology group QinetiQ has reaffirmed its outlook on the back of strong revenue visibility, while a review of its struggling US operations remains the key strategic question hanging over the shares.
QinetiQ (LSE: QQ), the FTSE 250 defence research, testing and technology group, has been one of the London market's more closely watched beneficiaries of rising European defence budgets. Its recent communications have focused on two themes: a record order backlog built largely on contracts in Britain and its other home markets, and an ongoing reassessment of its US business, which has struggled in a difficult American defence services market. The group has also continued to buy back its own shares, publishing a regular sequence of transaction notices through the autumn.
A strong year for orders
Full-year results on 21 May showed revenue broadly flat at £1.92bn for the year to 31 March, but underlying pre-tax profit rose 16% to £230m. The standout figure was order intake, which jumped 83% to £3.57bn, driven mainly by contracts in its Europe, Middle East and Africa operations. That lifted the order backlog to £4.42bn. Underlying earnings per share were 31.5p and the underlying operating margin was 11.3%.
Alongside those results, QinetiQ raised its guidance for the current financial year, forecasting revenue growth of 3% to 5% and an operating margin of 11.0% to 11.5%, compared with earlier expectations of around 3% organic growth and an 11% margin. The shares rose as much as 11% on the day, to around 477p, making the company the biggest riser on the pan-European STOXX 600 index.
Reviewing the US business
The same announcement confirmed that QinetiQ was reviewing all options for its US operations, which accounted for about 15% of group revenue in the last financial year and generate annual revenue of roughly $385m. The company has pointed to a tough market in US defence services, citing budget pressures, a shift in spending towards platforms and hardware programmes, and slower contract awards. It has already been simplifying its American portfolio, including the earlier disposal of non-core units.
Analysts at Jefferies said that an exit would probably come at a significant discount to what QinetiQ originally paid for its US acquisitions, but argued that it would leave a more focused, higher-quality group. No outcome to the review has yet been announced, and any decision is likely to be a significant factor in how the market values the remaining business.
First quarter on track
In a trading update on 16 July, QinetiQ said performance in the three months to 30 June was consistent with its full-year expectations, supported by strong revenue visibility and a record opening order backlog. It confirmed guidance for revenue growth of 3% to 5%, an underlying operating margin of 11.0% to 11.5% and earnings per share growth of 8% to 10%. The company expects the first half to account for around 46% of annual revenue. Despite the reassurance, the shares slipped 1.9% to 442.2p that morning. QinetiQ also used the Farnborough International Airshow later that month to showcase a new laser source technology subsystem.
The road to the interims
The group's half-year results, due later in the autumn, will be the next major checkpoint. Investors are likely to focus on how quickly the order backlog converts into revenue, the margin trajectory in its UK and Australian businesses, and any progress on the US review. The wider backdrop remains supportive, with European governments committing to higher defence spending, although the timing of contract awards and procurement decisions can create volatility for suppliers.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...